Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 3.13 M3.26 M1.93 M3.89 M3.9 M 12.99 M Research & development 825 K1.06 M597 K1.61 M2.03 M 5.3 M Operating income -462 K-4.34 M-2.49 M-5.51 M-5.93 M -18.27 M Non-Operating Income, Total 9.56 M-2.3 M-2.04 M-31.63 M-5.86 M -41.84 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 9.45 M-2.4 M-2.11 M-31.65 M-5.89 M -42.05 M Unusual income/expense 103 K92 K68 K27 K30 K 217 K Pretax income 9.1 M-6.64 M-4.54 M-37.14 M-11.79 M -60.11 M Equity in earnings ————— — Taxes ———-4.65 M— — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 9.1 M-6.64 M-4.54 M-37.14 M-11.79 M -60.11 M Discontinued operations ————— — Net income 9.1 M-6.64 M-4.54 M-37.14 M-11.79 M -60.11 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 9.1 M-6.64 M-4.54 M-37.14 M-11.79 M -60.11 M Basic earnings per share (Basic EPS) 2.28-0.6-0.39-5.24-0.29 -6.52 Diluted earnings per share (Diluted EPS) 2.28-0.6-0.39-5.24-0.29 -6.52 Average basic shares outstanding 3.98 M11.09 M11.63 M9.92 M40.61 M — Diluted shares outstanding 3.98 M11.09 M11.63 M9.92 M40.61 M — EBITDA ————-5.99 M — EBIT ————-6.01 M — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 19 K20 K19 K20 K19 K 78 K